Please assess the completion status of the following clinical trial:

Trial Title: Volume Restoration of the Aging Midface With Sculptra Aesthetic

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 40-60 years old~* BMI greater than 18.5 and less than 24.9~Exclusion Criteria:~* Age less than 40 years or greater than 60 years~* Prior surgical or non-surgical treatment to the midface within the past 2 years~* Interested in seeking other treatments to the midface during the study period~* Pregnant, lactating, or breast feeding~* Hypersensitivity to poly-L-lactic acid, carboxymethylcellulose, or mannitol~* Allergy to lidocaine or epinephrine~* History of atopy, anaphylaxis, or multiple severe allergies~* Current immunotherapy or history of autoimmune disease~* History of or active stroke or myocardial infarction~* History of or active connective tissue disease~* History of or active bleeding disorders~* History of or active cancer~* Serious abnormalities in laboratory findings~* Active hepatitis~* Active infection or inflammatory process of skin~* History of or risk factors for hypertrophic scarring or keloid formation

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Sculptra Aesthetic (Type: EXPERIMENTAL): Patients receiving Sculptra Aesthetic

Based on this trial design, predict the completion outcome and termination type (if applicable).